0001103021-21-000002.txt : 20210120 0001103021-21-000002.hdr.sgml : 20210120 20210120163026 ACCESSION NUMBER: 0001103021-21-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coelho Mary Theresa CENTRAL INDEX KEY: 0001720772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 21539112 MAIL ADDRESS: STREET 1: 52 SUNRISE PARK ROAD CITY: NEW HAMPTON STATE: NY ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_161117821292460.xml FORM 4 X0306 4 2021-01-15 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001720772 Coelho Mary Theresa C/O BIODELIVERY SCIENCES INTL, INC. 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 See Remarks Common Stock 2021-01-15 4 M 0 18333 0 A 30351 D Common Stock 2021-01-19 4 S 0 6462 4.32 D 23889 D Restricted Stock Units 0.0 2021-01-15 4 M 0 18333 0 D 2020-01-15 2022-01-17 Common Stock 18333.0 18334 D The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan. On January 19, 2021, the Reporting Person sold an aggregate of 6,462 shares of the Issuer's Common Stock at a weighted average price of $4.32 per share. The highest sale price for the Common Stock was $4.34 per share and the lowest sale price was $4.32 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest on January 15, 2022. Chief Financial Officer and Treasurer /s/ Mary Theresa Coelho 2021-01-20